CStone Pharmaceuticals has filed an updated list of directors and their roles with the Hong Kong Stock Exchange. The Board consists of Dr. Jianxin Yang (Executive Director and Chief Executive Officer), Dr. Wei Li (Non-executive Director and Chairman), Mr. Kenneth Walton Hitchner III (Non-executive Director), and Mr. Edward Hu (Non-executive Director). Independent Non-executive Directors include Mr. Kenneth Howard Jarrett, Ms. Fang Xie, and Ms. Catherine Yen. Committee memberships are as follows: Dr. Jianxin Yang chairs the Strategy Committee; Dr. Wei Li chairs the Nomination Committee and is a member of the Strategy Committee; Mr. Kenneth Walton Hitchner III is a member of the Investment Committee; Mr. Edward Hu chairs the Investment Committee and is a member of the Strategy Committee; Mr. Kenneth Howard Jarrett is a member of the Audit and Strategy Committees; Ms. Fang Xie chairs the Audit Committee, and is a member of the Compensation, Nomination, and Investment Committees; and Ms. Catherine Yen chairs the Compensation Committee and is a member of the Audit and Nomination Committees.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CStone Pharmaceuticals published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260121-11997555), on January 21, 2026, and is solely responsible for the information contained therein.